Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
53M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$1.92B
-
Value change
-
+$58M
-
Put/Call ratio
-
2.16
-
Number of buys
-
102
-
Number of sells
-
-77
-
Price
-
$36.18
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2024
201 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q2 2024.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53M shares
of 64.3M outstanding shares and own 82.38% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (4.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.62M shares), BlackRock Inc. (3.34M shares), FMR LLC (2.8M shares), Sofinnova Investments, Inc. (2.79M shares), VANGUARD GROUP INC (2.52M shares), COMMODORE CAPITAL LP (2.48M shares), STATE STREET CORP (2.16M shares), Eversept Partners, LP (2.04M shares), and Holocene Advisors, LP (1.8M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.